Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Supplemental cash flow information:
Interest paid	$ 4,824	$ 7,086	$ 8,038
Income taxes paid (refunded), net	1,819	2	26
Supplemental disclosure of non-cash financing activities:
Reclassification of contingently redeemable common stock in connection with IPO	309,500	0	0
Issuance of common stock under partner physician group equity agreements upon IPO	268,467	0	0
Offering costs accrued at end of period	295	0	0
Non-cash investment in unconsolidated subsidiaries	763	0	0
Settlement of stock-based liabilities	0	1,500	5,000
Settlement of loans receivable with services provided	$ 0	$ 2,047	$ 0